U.S. CDMO Capacity

More Than Capacity: What the Latest U.S. CDMO Expansion Wave Reveals About Specialized Manufacturing Demand

Pharma's Almanac

Small Molecules

State of the Industry 2026 Virtual Panel: Small Molecules

Nice Insight

Advanced Therapies

State of the Industry 2026 Virtual Panel: Advanced Therapies (pt. 2)

Nice Insight

Advanced Therapies

State of the Industry 2026 Virtual Panel: Advanced Therapies (pt. 1)

Nice Insight

Biologics

State of the Industry 2026 Virtual Panel: Biologics

Nice Insight

Oncology

From Chemo to Advanced Therapies: New Frontiers in Oncology

Serene Lee

Nice Insight

Gene Therapy

Gene Therapy at 30: Milestones, Setbacks, and a Path Forward

Cynthia A. Challener, Ph.D.

Pharma's Almanac

First-in-Class Drugs

Breaking New Ground: 30 Years of First-in-Class Drug Innovation

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Supply Chain

Building Resilient Pharma Supply Chains in an Uncertain World

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Cell Therapy

Expanding the Frontiers of Cell Therapy: Veterinary Applications and Translational Insights

April Stanley, MS MBA; Sophie Lutter, Ph.D.

Nice Insight

RNA

Is mRNA a Gene Therapy? Unpacking the Evolving Regulatory Debate

April Stanley, MS MBA; Cynthia A. Challener, Ph.D.

Nice Insight

SUT

From Niche to Necessity: How Single-Use Transformed Biomanufacturing

Cynthia A. Challener, Ph.D.

Pharma's Almanac

RNA

Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics

David Alvaro, Ph.D.

Pharma's Almanac

Genomics

Genomics and the Next Era of Precision Medicine

David Alvaro, Ph.D.

Pharma's Almanac

Aging

Resetting the Biological Clock: OKSM and the Reversal of Aging

David Alvaro, Ph.D.

Pharma's Almanac

Global Trials

Clinical Trials Without Borders: The Evolution of Global Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

LOGIC GATES

Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies

David Alvaro, Ph.D.

Pharma's Almanac

Space

The Final Frontier: Biomanufacturing in Space

David Alvaro, Ph.D.

Pharma's Almanac

Advocacy

From Patients to Partners: The Rising Power of Advocacy in Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

DCTs

Accelerating Patient Access Through Decentralized Clinical Trials

Cynthia A. Challener, Ph.D.

Pharma's Almanac